Reference
Therapeutic Goods Administration (TGA). Ceftriaxone and risk of hepatitis and encephalopathy. Internet Document : 15 Dec 2021. Available from: URL: https://www.tga.gov.au/publication-issue/ceftriaxone-and-risk-hepatitis-and-encephalopathy
Rights and permissions
About this article
Cite this article
TGA updates ceftriaxone product information to include risk of encephalopathy and hepatitis. Reactions Weekly 1887, 6 (2022). https://doi.org/10.1007/s40278-022-07671-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-07671-3